SRI-45949 is an allosteric modulator of the HIV-DAT-Tat interaction. The IC50 values for SRI-45949 in [3H] DA uptake and [3H] WIN35,428 binding are 9.56 µM and 9.34 µM, respectively. This compound is useful for research related to HIV-associated neurocognitive disorders.
Target:
Dopamine Receptor|||HIV Protease
* VAT and and shipping costs not included. Errors and price changes excepted
